Cargando…
Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells
SIMPLE SUMMARY: Neuroblastoma is a childhood cancer with poor survival and new therapies are urgently needed, especially for high-risk disease. Here, we demonstrate that novel drugs targeting a protein called ATR can specifically kill a type of high-risk neuroblastoma associated with MYCN expression...
Autores principales: | King, David, Southgate, Harriet E. D., Roetschke, Saskia, Gravells, Polly, Fields, Leona, Watson, Jessica B., Chen, Lindi, Chapman, Devon, Harrison, Daniel, Yeomanson, Daniel, Curtin, Nicola J., Tweddle, Deborah A., Bryant, Helen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699051/ https://www.ncbi.nlm.nih.gov/pubmed/34944835 http://dx.doi.org/10.3390/cancers13246215 |
Ejemplares similares
-
ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms
por: Southgate, Harriet E. D., et al.
Publicado: (2020) -
Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020) -
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
por: King, David, et al.
Publicado: (2020) -
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
por: King, David, et al.
Publicado: (2023) -
Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
por: Harrision, Daniel, et al.
Publicado: (2020)